ALESSANDRA FERRAJOLI to Evidence-Based Medicine
This is a "connection" page, showing publications ALESSANDRA FERRAJOLI has written about Evidence-Based Medicine.
Connection Strength
0.329
-
Evidence-based mini-review: the role of alkylating agents in the initial treatment of chronic lymphocytic leukemia patients with the 11q deletion. Hematology Am Soc Hematol Educ Program. 2010; 2010:90-2.
Score: 0.238
-
Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia. Cancer. 2011 Jul 15; 117(14):3268-75.
Score: 0.064
-
An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma. Clin Lymphoma Myeloma Leuk. 2018 08; 18(8):508-518.e14.
Score: 0.027